.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076842

« Back to Dashboard
NDA 076842 describes HYDROCORTISONE BUTYRATE, which is a drug marketed by Taro, Glenmark Generics, and Taro Pharm Inds, and is included in four NDAs. It is available from two suppliers. Additional details are available on the HYDROCORTISONE BUTYRATE profile page.

The generic ingredient in HYDROCORTISONE BUTYRATE is hydrocortisone butyrate. There are fifty-six drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the hydrocortisone butyrate profile page.

Summary for NDA: 076842

Tradename:
HYDROCORTISONE BUTYRATE
Applicant:
Taro
Ingredient:
hydrocortisone butyrate
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details

Pharmacology for NDA: 076842

Suppliers and Packaging for NDA: 076842

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
HYDROCORTISONE BUTYRATE
hydrocortisone butyrate
OINTMENT;TOPICAL 076842 ANDA Taro Pharmaceuticals U.S.A., Inc. 51672-4083 51672-4083-1 1 TUBE in 1 CARTON (51672-4083-1) > 15 g in 1 TUBE
HYDROCORTISONE BUTYRATE
hydrocortisone butyrate
OINTMENT;TOPICAL 076842 ANDA Taro Pharmaceuticals U.S.A., Inc. 51672-4083 51672-4083-2 1 TUBE in 1 CARTON (51672-4083-2) > 30 g in 1 TUBE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:OINTMENT;TOPICALStrength0.1%
Approval Date:Dec 27, 2004TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc